Credential Qtrade Securities Inc. Biomarin Pharmaceutical Inc Transaction History

Credential Qtrade Securities Inc.

  • $1.86 Trillion
  • Q1 2024

A detailed history of Credential Qtrade Securities Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Credential Qtrade Securities Inc. holds 9,827 shares of BMRN stock, worth $579,891. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,827
Previous 9,660 1.73%
Holding current value
$579,891
Previous $931 Million 7.85%
% of portfolio
0.05%
Previous 0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 21, 2025
BUY
$83.81 - $99.0 $13,996 - $16,533
167 Added 1.73%
9,827 $858 Million
Q4 2023

Jul 21, 2025
SELL
$76.22 - $98.51 $37,119 - $47,974
-487 Reduced 4.8%
9,660 $931 Million
Q3 2023

Jul 21, 2025
BUY
$85.07 - $94.48 $3,998 - $4,440
47 Added 0.47%
10,147 $898 Million
Q2 2023

Jul 21, 2025
BUY
$86.68 - $100.3 $232,475 - $269,004
2,682 Added 36.16%
10,100 $875 Million
Q1 2023

Jul 21, 2025
BUY
$87.74 - $117.27 $298,579 - $399,069
3,403 Added 84.76%
7,418 $721 Million
Q4 2022

Jul 21, 2025
SELL
$80.93 - $108.63 $4,208 - $5,648
-52 Reduced 1.28%
4,015 $416 Million
Q3 2022

Jul 21, 2025
BUY
$82.16 - $96.94 $11,748 - $13,862
143 Added 3.64%
4,067 $345 Million
Q2 2022

Jul 21, 2025
SELL
$71.48 - $86.85 $194,068 - $235,797
-2,715 Reduced 40.89%
3,924 $325 Million
Q1 2022

Jul 21, 2025
BUY
$74.28 - $92.69 $25,329 - $31,607
341 Added 5.41%
6,639 $512 Million
Q4 2021

Jul 21, 2025
BUY
$71.72 - $91.47 $6,167 - $7,866
86 Added 1.38%
6,298 $556 Million
Q3 2021

Jul 21, 2025
BUY
$74.77 - $85.47 $24,748 - $28,290
331 Added 5.63%
6,212 $480 Million
Q2 2021

Jul 21, 2025
BUY
$75.51 - $84.79 $58,520 - $65,712
775 Added 15.18%
5,881 $491 Million
Q1 2021

Jul 21, 2025
BUY
$74.73 - $90.69 $175,540 - $213,030
2,349 Added 85.2%
5,106 $386 Million
Q3 2020

Jul 21, 2025
BUY
$71.87 - $131.03 $126,563 - $230,743
1,761 Added 176.81%
2,757 $210 Million
Q2 2020

Jul 21, 2025
BUY
$79.55 - $124.22 $10,102 - $15,775
127 Added 14.61%
996 $123 Million
Q1 2020

Jul 21, 2025
SELL
$71.37 - $96.85 $76,009 - $103,145
-1,065 Reduced 55.07%
869 $73.4 Million
Q4 2019

Jul 21, 2025
BUY
$64.27 - $86.37 $40,939 - $55,017
637 Added 49.11%
1,934 $164 Million
Q3 2019

Jul 21, 2025
BUY
$67.4 - $85.11 $1,415 - $1,787
21 Added 1.65%
1,297 $87.4 Million
Q2 2019

Jul 21, 2025
SELL
$80.35 - $93.9 $88,545 - $103,477
-1,102 Reduced 46.34%
1,276 $109 Million
Q1 2019

Jul 21, 2025
SELL
$84.2 - $98.62 $6,651 - $7,790
-79 Reduced 3.22%
2,378 $211 Million
Q4 2018

Jul 21, 2025
BUY
$80.14 - $106.07 $47,282 - $62,581
590 Added 31.6%
2,457 $209 Million
Q3 2018

Jul 21, 2025
BUY
$93.92 - $105.72 $175,348 - $197,379
1,867 New
1,867 $181 Million

Others Institutions Holding BMRN

# of Institutions
666
Shares Held
185M
Call Options Held
1.24M
Put Options Held
957K
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Credential Qtrade Securities Inc. Portfolio

Follow Credential Qtrade Securities Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on Credential Qtrade Securities Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email